Researchers are excited about the medication , a novel dual treatment showing significant results in early trials for size loss . It works by impacting both pathways : GLP-1 and GIP, which , when activated , support control appetite and enhance metabolism . Preliminary reports suggest substantial weight reduction and potential benefits for individu